Novartis acquires Kate Therapeutics to advance gene therapies

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited neuromuscular diseases.

Related Posts

STAT+: Beleaguered drug manufacturer Emergent cuts jobs...

Aug 9, 2023

With FDA greenlight, BMS Breyanzi brings CAR-T cell the...

Mar 16, 2024

How did hiring in the pharma industry perform in Q3 2023?

Oct 19, 2023